首页> 美国卫生研究院文献>Journal of Clinical Microbiology >A Comprehensive Evaluation of the Proficiency Testing Program for the HIV-1 BED Incidence Assay
【2h】

A Comprehensive Evaluation of the Proficiency Testing Program for the HIV-1 BED Incidence Assay

机译:HIV-1 BED发病率检测能力测试计划的综合评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The HIV-1 BED incidence assay was developed at the Centers for Disease Control and Prevention and since 2005 has been available as a commercial kit for use in HIV-1 incidence surveillance. A BED-specific proficiency testing (PT) program was initiated in 2006 that included a panel of eight coded specimens (six unique and two duplicates) to participating laboratories. The number of participating laboratories increased from 12 to 38 from 2006 to 2009. Overall, 96.1% of the laboratories reported results, and 95.4% of those reporting achieved a 100% score. The observed mean normalized optical density (OD-n) values of all participants correlated well with the expected OD-n values for all specimens (R2 = 0.98) used for seven PT rounds. BED testing demonstrated high reproducibility among all laboratories, with an agreement of 99.3% (574/578) between initial and confirmatory classification and regression statistics of R2 = 0.96, slope = 1.022, and intercept = 0.0066. Reproducibility among duplicate specimens was very high during each PT round, with mean deviation of 1.8%. Analysis of controls and calibrator specimen for all 343 runs showed a coefficient of variation of ca. 20% for raw ODs in the dynamic range, which was reduced to <10% when the OD was normalized (OD-n). Most laboratories that failed the PT assessment had transcriptional errors, kit reagent problems, or specimen handling errors. Thus, the BED-specific PT program enabled us to track performance of different laboratories conducting the BED assay while identifying areas for improvements. This program will also serve as a template for future PT programs for new incidence assays as they become available.
机译:HIV-1 BED发病率测定是由疾病控制与预防中心开发的,自2005年以来,已作为用于HIV-1发病率监测的商业工具包提供。一项针对BED的能力验证(PT)计划于2006年启动,其中包括参加实验室的八个编码标本(六个唯一和两个重复)的小组。从2006年到2009年,参与实验室的数量从12个增加到38个。总体而言,有96.1%的实验室报告了结果,而有95.4%的实验室报告了100%的得分。观察到的所有参与者的平均归一化光密度(OD-n)值与用于7个PT循环的所有标本的预期OD-n值(R 2 = 0.98)很好地相关。 BED测试显示所有实验室之间都具有很高的可重复性,初始和确认分类与回归统计之间的一致性为99.3%(574/578),R 2 = 0.96,斜率= 1.022,截距= 0.0066。在每个PT轮中,重复样本之间的可重复性非常高,平均偏差为1.8%。对所有343次运行的对照和校准品样本的分析均显示出ca的变异系数。动态范围内原始OD的20%,当OD归一化(OD-n)时降低到<10%。大多数未通过PT评估的实验室都有转录错误,试剂盒试剂问题或标本处理错误。因此,特定于BED的PT程序使我们能够跟踪进行BED分析的不同实验室的性能,同时确定需要改进的地方。该程序还将作为未来PT程序的模板,以用于新的发生率测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号